Desmopressin Acetate Patent Expiration

1. Ddavp patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5500413 FERRING PHARMS INC Process for manufacture of 1-deamino-8-D-arginine vasopressin
Jun, 2013

(11 years ago)

US5763407 FERRING PHARMS INC High-purity desmopressin produced in large single batches
Jun, 2013

(11 years ago)

US5674850 FERRING PHARMS INC High purity desmopressin produced in large single batches
Dec, 2013

(10 years ago)

US7022340 FERRING PHARMS INC Pharmaceutical composition as solid dosage form and method for manufacturing thereof
Apr, 2023

(1 year, 2 months ago)




Market Authorisation Date: 30 March, 1984

Treatment: NA

Dosage: INJECTABLE; TABLET; SOLUTION; SPRAY, METERED

How can I launch a generic of DDAVP before it's drug patent expiration?
More Information on Dosage

DDAVP family patents

Family Patents

2. Ddavp (needs No Refrigeration) patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5482931 FERRING PHARMS INC Stabilized pharmaceutical peptide compositions
Jun, 2013

(11 years ago)

US5500413 FERRING PHARMS INC Process for manufacture of 1-deamino-8-D-arginine vasopressin
Jun, 2013

(11 years ago)

US5763407 FERRING PHARMS INC High-purity desmopressin produced in large single batches
Jun, 2013

(11 years ago)

US5674850 FERRING PHARMS INC High purity desmopressin produced in large single batches
Dec, 2013

(10 years ago)




Market Authorisation Date: 01 January, 1982

Treatment: NA

Dosage: SPRAY, METERED

How can I launch a generic of DDAVP (NEEDS NO REFRIGERATION) before it's drug patent expiration?
More Information on Dosage

DDAVP (NEEDS NO REFRIGERATION) family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Desmopressin Acetate patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7022340 FERRING Pharmaceutical composition as solid dosage form and method for manufacturing thereof
Apr, 2023

(1 year, 2 months ago)




Market Authorisation Date: 08 May, 2008

Treatment: NA

Dosage: TABLET

More Information on Dosage

DESMOPRESSIN ACETATE family patents

Family Patents

4. Nocdurna patent expiration

NOCDURNA's oppositions filed in EPO
NOCDURNA IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9220747 FERRING PHARMS INC Methods using desmopressin acetate in orodispersible form
May, 2023

(1 year, 2 months ago)

US9504647 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(1 year, 2 months ago)

US10307459 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(1 year, 2 months ago)

US9919025 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(1 year, 2 months ago)

US8802624 FERRING PHARMS INC Methods of treatment using orodispersible desmopressin pharmaceutical formulations
Dec, 2023

(6 months ago)

US7947654 FERRING PHARMS INC Pharmaceutical formulations
Dec, 2023

(6 months ago)

US7560429 FERRING PHARMS INC Orodispersible dosage forms of desmopressin acetate
Feb, 2024

(5 months ago)

US11020448 FERRING PHARMS INC Methods comprising desmopressin
May, 2029

(4 years from now)

US10137167 FERRING PHARMS INC Methods comprising desmopressin
May, 2029

(4 years from now)

US9974826 FERRING PHARMS INC Methods comprising desmopressin
Apr, 2030

(5 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jun 21, 2021

Market Authorisation Date: 21 June, 2018

Treatment: Treatment of nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults, comprising monitoring a patient's serum sodium concentration

Dosage: TABLET

More Information on Dosage

NOCDURNA family patents

Family Patents

5. Noctiva patent expiration

NOCTIVA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7405203 ACERUS PHARMS Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(1 year, 2 months ago)

US7579321 ACERUS PHARMS Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(1 year, 2 months ago)

US7799761 ACERUS PHARMS Pharmaceutical compositions including low dosages of desmopressin
Sep, 2024

(2 months from now)

US11419914 ACERUS PHARMS Safe desmopressin administration
Jun, 2030

(5 years from now)

US9539302 ACERUS PHARMS Safe desmopressin administration
Jun, 2030

(5 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Mar 03, 2020

Market Authorisation Date: 03 March, 2017

Treatment: A method of treating nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void by inducing an antidiuretic e...

Dosage: SPRAY, METERED

More Information on Dosage

NOCTIVA family patents

Family Patents